Treace Medical Concepts, Inc. provided revenue guidance for the year 2024. For the period, the company expects revenue to be $220 million to $225 million, which represents approximately 18% to 20% growth over full-year 2023 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.91 USD | -3.27% | +0.51% | -53.65% |
May. 29 | Treace Medical Concepts Insider Bought Shares Worth $253,475, According to a Recent SEC Filing | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.65% | 366M | |
-24.88% | 7.32B | |
+7.04% | 6.66B | |
+15.10% | 5.5B | |
-17.34% | 4.88B | |
+14.96% | 4.1B | |
-20.83% | 3.89B | |
-25.03% | 2.83B | |
+44.01% | 2.31B | |
+2.10% | 2.07B |
- Stock Market
- Equities
- TMCI Stock
- News Treace Medical Concepts, Inc.
- Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024